Quick Answer
LEXICON PHARMACEUTICALS, INC. reported Net Income Loss of -$50.34 million for the year ending 2025.
- LEXICON PHARMACEUTICALS, INC. showed an increase of +74.9% in Net Income Loss from 2024 to 2025.
- This data is from LEXICON PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), LEXICON PHARMACEUTICALS, INC.'s Net Income Loss has grown by 39.2%.
- Historical annual values: Fiscal year 2025: -$50.34 million | Fiscal year 2024: -$200.40 million | Fiscal year 2023: -$177.12 million | Fiscal year 2022: -$101.94 million | Fiscal year 2021: -$87.76 million | Fiscal year 2020: -$58.57 million | Fiscal year 2019: $130.13 million | Fiscal year 2018: -$120.55 million | Fiscal year 2017: -$122.99 million | Fiscal year 2016: -$131.45 million | Fiscal year 2015: -$4.68 million | Fiscal year 2014: -$100.29 million | Fiscal year 2013: -$104.13 million | Fiscal year 2012: -$110.21 million | Fiscal year 2011: -$116.22 million | Fiscal year 2010: -$101.78 million | Fiscal year 2009: -$82.78 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: